Comparison of four methods for quantitative measurement of hepatitis B viral DNA

被引:44
作者
Butterworth, LA
Prior, SL
Buda, PJ
Faoagali, JL
Cooksley, WGE
机构
[1] ROYAL BRISBANE HOSP,RES FDN,CLIN RES CTR,BRISBANE,QLD,AUSTRALIA
[2] ROYAL BRISBANE HOSP,DEPT MICROBIOL,BRISBANE,QLD,AUSTRALIA
关键词
branching oligonucleotide; chemiluminescence; DNA hybridization; hepatitis B viral DNA; quantitative measurement;
D O I
10.1016/S0168-8278(96)80264-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims/Methods: Four assays for measuring HBV-DNA quantitatively have been compared with regard to sensitivity, precision and linearity. The methods were I-125-labelled solution hybridisation assay (liquid hybridisation, Abbott), an ELISA-based chemiIuminescent RNA-DNA hybrid assay (RNA-DNA, Digene), a chemilumimescent branching oligonucleotide assay (bDNA, Chiron) and a membrane hybridisation assay using slot-blot equipment (slot blot). Results: The bDNA assay was linear over three orders of magnitude and was the most sensitive assay, being approximately ten times more sensitive than the other assays, so that samples negative on RNA-DNA, liquid hybridisation and slot blot gave quantifiable results on bDNA, Furthermore, intra- and inter-assay variability showed that the bDNA and liquid hybridisation assays had the greatest precision, with coefficients of variation of 6.6% to 11.5% and 2.3% to 10.5%, respectively. However, the nominated amounts of HBV DNA in the standards (from all assays) were plot reproducible in the other assays, such that amounts measured with bDNA would give values approximately twice that of RNA-DNA and 60 times that of liquid hybridisation. Conclusions: The recently developed bDNA assay has advantages compared with the other assays in quantitating samples with low levels of virus present, In addition, since the assays vary considerably by a number of criteria, the method of measurement should always be reported.
引用
收藏
页码:686 / 691
页数:6
相关论文
共 9 条
  • [1] AN ASSAY FOR THE DETECTION OF THE DNA GENOME OF HEPATITIS-B VIRUS IN SERUM
    BERNINGER, M
    HAMMER, M
    HOYER, B
    GERIN, JL
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1982, 9 (01) : 57 - 68
  • [2] KUHNS MC, 1988, VIRAL HEPATITIS LIVE, P258
  • [3] Lok A S, 1994, J Viral Hepat, V1, P105, DOI 10.1111/j.1365-2893.1994.tb00110.x
  • [4] A RANDOMIZED, CONTROLLED TRIAL OF INTERFERON ALFA-2B ALONE AND AFTER PREDNISONE WITHDRAWAL FOR THE TREATMENT OF CHRONIC HEPATITIS-B
    PERRILLO, RP
    SCHIFF, ER
    DAVIS, GL
    BODENHEIMER, HC
    LINDSAY, K
    PAYNE, J
    DIENSTAG, JL
    OBRIEN, C
    TAMBURRO, C
    JACOBSON, IM
    SAMPLINER, R
    FEIT, D
    LEFKOWITCH, J
    KUHNS, M
    MESCHIEVITZ, C
    SANGHVI, B
    ALBRECHT, J
    GIBAS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (05) : 295 - 301
  • [5] SCOTTO J, 1983, HEPATOLOGY, V3, P279
  • [6] Thomas H C, 1994, J Viral Hepat, V1, P139, DOI 10.1111/j.1365-2893.1994.tb00113.x
  • [7] URDEA MS, 1990, LUMINESCENCE IMMUNOA, P275
  • [8] COMPARISON OF METHODS FOR DETECTION OF HEPATITIS-B VIRUS-DNA
    ZAAIJER, HL
    TERBORG, F
    CUYPERS, HTM
    HERMUS, MCAH
    LELIE, PN
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (09) : 2088 - 2091
  • [9] DIGENE TECHNICAL B